Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2023-05-17 00:00:00 ET · period of report 2023-05-15 · accession 0001209191-23-030141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-17 | 2023-05-15 | PCRX | HASTINGS PAUL J | Dir | M - OptEx | $29.90 | +7,000 | 14.2K | +98% | +$209.3K |
| D | 2023-05-17 | 2023-05-15 | PCRX | HASTINGS PAUL J | Dir | S - Sale+OE | $41.85 | -7,000 | 7,179 | -49% | -$292.9K |
| D | 2023-05-17 | 2023-05-15 | PCRX | HASTINGS PAUL J | Dir | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-15 | M | A | 7,000 | $29.90 | 14,179 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-15 | S | D | 7,000 | $41.85 | 7,179 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-05-15 | M | D | 7,000 | $0.00 | 0 | D | $29.90 · — to 2023-06-12 | 7,000 Common Stock | (F2) The stock option vested and became exercisable in twelve equal monthly installments, with the first installment being on July 12, 2013. |